Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Harvard Bioscience (HBIO) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to -$1.2 million.

  • Harvard Bioscience's Profit After Tax rose 7436.48% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$53.8 million, marking a year-over-year decrease of 27802.82%. This contributed to the annual value of -$12.4 million for FY2024, which is 26325.04% down from last year.
  • According to the latest figures from Q3 2025, Harvard Bioscience's Profit After Tax is -$1.2 million, which was up 7436.48% from -$2.3 million recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Profit After Tax ranged from a high of $2.4 million in Q2 2022 and a low of -$50.3 million during Q1 2025
  • Its 5-year average for Profit After Tax is -$4.2 million, with a median of -$1.2 million in 2023.
  • Data for Harvard Bioscience's Profit After Tax shows a peak YoY increase of 69390.24% (in 2022) and a maximum YoY decrease of 190294.12% (in 2022) over the last 5 years.
  • Harvard Bioscience's Profit After Tax (Quarter) stood at $961000.0 in 2021, then tumbled by 273.36% to -$1.7 million in 2022, then dropped by 9.12% to -$1.8 million in 2023, then surged by 100.99% to $18000.0 in 2024, then crashed by 6938.89% to -$1.2 million in 2025.
  • Its Profit After Tax stands at -$1.2 million for Q3 2025, versus -$2.3 million for Q2 2025 and -$50.3 million for Q1 2025.